News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
66,476 Results
Type
Article (1753)
Company Profile (125)
Press Release (64598)
Section
Business (30060)
Career Advice (41)
Deals (4289)
Drug Delivery (2)
Drug Development (7089)
Employer Resources (10)
FDA (1348)
Job Trends (1654)
News (40817)
Policy (2096)
Tag
2027 Pharm Country Standard (1)
Academia (148)
Accelerated approval (7)
Allergies (21)
Alliances (2273)
ALS (6)
Alzheimer's disease (128)
Antibody-drug conjugate (ADC) (51)
Approvals (1455)
Artificial intelligence (46)
Autoimmune disease (25)
Bankruptcy (19)
Best Places to Work (1638)
Biosimilars (9)
Biotechnology (55)
Bladder cancer (32)
Brain cancer (5)
Breast cancer (129)
Cancer (727)
Cardiovascular disease (48)
Career advice (39)
Career pathing (1)
CAR-T (21)
Cell therapy (64)
Cervical cancer (8)
Clinical research (6895)
Collaboration (113)
Compensation (86)
Complete response letters (4)
COVID-19 (151)
CRISPR (6)
C-suite (27)
Cystic fibrosis (16)
Data (1028)
Depression (8)
Diabetes (51)
Diagnostics (801)
Digital health (5)
Diversity, equity & inclusion (1)
Drug discovery (12)
Drug pricing (6)
Duchenne muscular dystrophy (17)
Earnings (28719)
Employer branding (3)
Employer resources (8)
Events (6849)
Executive appointments (26)
FDA (1893)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (69)
Gene editing (13)
Generative AI (6)
Gene therapy (57)
GLP-1 (98)
Government (258)
Guidances (263)
Healthcare (1923)
HIV (16)
Huntington's disease (2)
IgA nephropathy (15)
Immunology and inflammation (22)
Immuno-oncology (8)
Indications (22)
Infectious disease (174)
Inflammatory bowel disease (26)
Influenza (8)
Intellectual property (19)
Interviews (2)
IPO (3329)
IRA (2)
Job creations (140)
Job search strategy (35)
JPM (2)
Kidney cancer (5)
Labor market (12)
Layoffs (38)
Leadership (3)
Legal (323)
Liver cancer (5)
Lung cancer (122)
Lymphoma (90)
Machine learning (2)
Management (3)
Manufacturing (36)
MASH (28)
Medical device (1786)
Medtech (1798)
Mergers & acquisitions (1041)
Metabolic disorders (139)
mRNA (5)
Multiple sclerosis (34)
NASH (6)
Neurodegenerative disease (23)
Neuropsychiatric disorders (13)
Neuroscience (247)
NextGen: Class of 2026 (560)
Non-profit (251)
Now hiring (2)
Obesity (61)
Opinion (6)
Ovarian cancer (11)
Pain (22)
Pancreatic cancer (22)
Parkinson's disease (22)
Partnered (3)
Patents (26)
Patient recruitment (26)
Peanut (7)
People (1928)
Pharmaceutical (37)
Pharmacy benefit managers (3)
Phase 1 (1484)
Phase 2 (2793)
Phase 3 (3046)
Pipeline (1784)
Policy (9)
Postmarket research (326)
Preclinical (418)
Press Release (8)
Prostate cancer (29)
Radiopharmaceuticals (27)
Rare diseases (80)
Real estate (201)
Recruiting (3)
Regulatory (1943)
Reports (14)
Research institute (120)
Resumes & cover letters (4)
Rett syndrome (9)
RSV (9)
Schizophrenia (23)
Series A (6)
Series B (6)
Service/supplier (5)
Sickle cell disease (13)
Special edition (5)
Spinal muscular atrophy (9)
Sponsored (2)
Startups (129)
Stomach cancer (2)
Supply chain (2)
Tariffs (1)
The Weekly (1)
Vaccines (70)
Venture capital (1)
Weight loss (30)
Women's health (11)
Worklife (1)
Date
Today (2)
Last 7 days (85)
Last 30 days (487)
Last 365 days (4202)
2026 (853)
2025 (4240)
2024 (4901)
2023 (5312)
2022 (6085)
2021 (6326)
2020 (5585)
2019 (4311)
2018 (3306)
2017 (2877)
2016 (1993)
2015 (2952)
2014 (2065)
2013 (1628)
2012 (1732)
2011 (1820)
2010 (1770)
Location
Africa (55)
Alabama (8)
Arizona (35)
Arkansas (1)
Asia (4588)
Australia (412)
California (1593)
Canada (440)
China (138)
Colorado (82)
Connecticut (74)
Delaware (63)
Europe (9078)
Florida (215)
Georgia (53)
Idaho (4)
Illinois (102)
India (16)
Indiana (129)
Iowa (3)
Japan (80)
Kansas (16)
Kentucky (4)
Louisiana (9)
Maine (45)
Maryland (214)
Massachusetts (1049)
Michigan (52)
Minnesota (128)
Missouri (14)
Montana (13)
Nebraska (1)
Nevada (21)
New Hampshire (14)
New Jersey (697)
New Mexico (2)
New York (424)
North Carolina (251)
Northern California (867)
Ohio (36)
Oregon (5)
Pennsylvania (347)
Rhode Island (3)
South America (91)
South Carolina (2)
Southern California (585)
Tennessee (13)
Texas (205)
United States (5946)
Utah (48)
Virginia (17)
Washington D.C. (5)
Washington State (125)
Wisconsin (22)
66,476 Results for "54".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Abbott increases quarterly dividend for 54th consecutive year
December 15, 2025
·
1 min read
influenza
Moderna Scores $54 Million From CEPI To Fund Bird Flu Vaccine
The money replaces a small portion of a contract Moderna lost when the Department of Health and Human Services canceled $760 million in backing to develop the vaccine, called mRNA-1018.
December 18, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
National Institutes of Health Awards $1.54M Grant To Scottish Rite for Children for Rare Diseases Research
January 8, 2026
·
3 min read
Press Releases
BD Board Increases Dividend for 54th Consecutive Year
November 6, 2025
·
2 min read
Earnings
Zepbound Topples Sales King Keytruda as Lilly Reports 54% YoY Revenue Rise for Q3
Mounjaro and Zepbound contributed more than $10 billion to the $11.98 billion in sales Lilly recorded for key products in the third quarter, despite price decreases for the GLP-1 medicines.
October 30, 2025
·
1 min read
·
Annalee Armstrong
Rare disease
Aardvark Tanks After Pausing Prader-Willi Study on ‘Surprise’ Safety Signals
Aardvark Therapeutics is down 54% since Friday after the biotech said it detected “reversible cardiac observations” in a healthy volunteer study of its drug to treat extreme hunger in patients with the rare genetic disease.
March 2, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Oncology Market Poised to Reach USD 600.97 Billion by 2034, Growing at 11.54% CAGR
September 22, 2025
·
1 min read
Press Releases
MaaT Pharma Presents Pivotal ARES Phase 3 Results for MaaT013 (Xervyteg®) in Acute GvHD at ASH 2025 Annual Congress and Announces 54% 1-Year Overall Survival
December 9, 2025
·
7 min read
Press Releases
U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care*
December 15, 2025
·
20 min read
Press Releases
Analytical Instrumentation Market Size to Expected USD 97.54 Billion by 2034
July 21, 2025
·
1 min read
1 of 6,648
Next
